These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 38980796

  • 1. Role of Omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) as modulatory and anti-inflammatory agents in noncommunicable diet-related diseases - Reports from the last 10 years.
    Banaszak M, Dobrzyńska M, Kawka A, Górna I, Woźniak D, Przysławski J, Drzymała-Czyż S.
    Clin Nutr ESPEN; 2024 Oct; 63():240-258. PubMed ID: 38980796
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS.
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beneficial effect of long-chain n-3 polyunsaturated fatty acid supplementation on tuberculosis in mice.
    Nienaber A, Ozturk M, Dolman RC, Zandberg L, Hayford FE, Brombacher F, Blaauw R, Smuts CM, Parihar SP, Malan L.
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jul; 170():102304. PubMed ID: 34082319
    [Abstract] [Full Text] [Related]

  • 8. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V, Macedo CR, de Souza Pedrosa A, Pereira Gomes Morais E, Porfírio GJ, Torloni MR.
    Cochrane Database Syst Rev; 2016 Aug 17; 2016(8):CD011014. PubMed ID: 27536971
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J, Hurt-Camejo E.
    Lipids Health Dis; 2017 Aug 10; 16(1):149. PubMed ID: 28797250
    [Abstract] [Full Text] [Related]

  • 11. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
    Welty FK, Daher R, Garelnabi M.
    Arterioscler Thromb Vasc Biol; 2024 Jan 10; 44(1):89-107. PubMed ID: 37916414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
    Wang IE, Yi S, Block RC, Mousa SA.
    Nutr Res Rev; 2022 Dec 10; 35(2):295-307. PubMed ID: 34253265
    [Abstract] [Full Text] [Related]

  • 14. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
    Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I.
    J Intern Med; 2022 May 10; 291(5):637-647. PubMed ID: 34982486
    [Abstract] [Full Text] [Related]

  • 15. Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA.
    Patterson AC, Chalil A, Aristizabal Henao JJ, Streit IT, Stark KD.
    Nutr Res; 2015 Dec 10; 35(12):1040-51. PubMed ID: 26500082
    [Abstract] [Full Text] [Related]

  • 16. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
    Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK.
    Am J Clin Nutr; 2010 May 10; 91(5):1185-94. PubMed ID: 20335550
    [Abstract] [Full Text] [Related]

  • 17. Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.
    Mason RP, Libby P, Bhatt DL.
    Arterioscler Thromb Vasc Biol; 2020 May 10; 40(5):1135-1147. PubMed ID: 32212849
    [Abstract] [Full Text] [Related]

  • 18. Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
    Pal A, Metherel AH, Fiabane L, Buddenbaum N, Bazinet RP, Shaikh SR.
    Nutrients; 2020 Dec 02; 12(12):. PubMed ID: 33276463
    [Abstract] [Full Text] [Related]

  • 19. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
    Allaire J, Couture P, Leclerc M, Charest A, Marin J, Lépine MC, Talbot D, Tchernof A, Lamarche B.
    Am J Clin Nutr; 2016 Aug 02; 104(2):280-7. PubMed ID: 27281302
    [Abstract] [Full Text] [Related]

  • 20. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse.
    Wang S, Wu D, Matthan NR, Lamon-Fava S, Lecker JL, Lichtenstein AH.
    Atherosclerosis; 2009 May 02; 204(1):147-55. PubMed ID: 18842266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.